In 2025, U.S. pharmaceutical manufacturers face an evolving regulatory landscape that presents both challenges and opportunities. With new legislative developments, evolving government programs, and increased focus on pricing transparency, the stakes are higher than ever. This webinar will bring together leading experts and thought leaders from across the industry to explore the latest regulatory trends shaping the future of compliance. The session will highlight actionable insights and strategies to help you navigate upcoming changes and ensure your organization is prepared for 2025 and beyond. Key topics include:

• The evolving 340B program
• Navigating state price transparency laws and emerging prescription drug affordability boards
• The ongoing impact of the Inflation Reduction Act (IRA) on Medicare, pricing, and pharmaceutical revenue strategies
• New federal guidance and potential regulations that will shape compliance in the coming year
• Join us for an engaging and informative discussion on what you need to know to stay ahead of regulatory changes and ensure continued compliance success in 2025.

Featured Speakers

John Shakow

Partner

King & Spalding

Jesse Mendelsohn

Senior Vice President

Model N

Ryan Maizel

Senior Director, Advisory Services

Model N